ANTUROL Trademark

Trademark Overview

On Tuesday, September 6, 2005, a trademark application was filed for ANTUROL with the United States Patent and Trademark Office. The USPTO has given the ANTUROL trademark a serial number of 78707557. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 13, 2015. This trademark is owned by Antares Pharma IPL AG. The ANTUROL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and medicines for the treatment of incontinence, namely, urinary incontinence and overactive bladder; medicaments to relieve symptoms of urinary incontinence and overactive bladder
anturol

General Information

Serial Number78707557
Word MarkANTUROL
Filing DateTuesday, September 6, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 13, 2015
Registration Number3604391
Registration DateTuesday, April 7, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations and medicines for the treatment of incontinence, namely, urinary incontinence and overactive bladder; medicaments to relieve symptoms of urinary incontinence and overactive bladder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 13, 2015
Primary Code005
First Use Anywhere DateWednesday, September 7, 2005
First Use In Commerce DateMonday, January 12, 2009

Trademark Owner History

Party NameAntares Pharma IPL AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressZug 6301
CH
Party NameAntares Pharma IPL AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZug 6301
CH
Party NameAntares Pharma IPL AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug 6301
CH

Trademark Events

Event DateEvent Description
Friday, November 13, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, April 7, 2009REGISTERED-PRINCIPAL REGISTER
Wednesday, March 4, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, March 4, 2009ASSIGNED TO LIE
Saturday, February 28, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, February 13, 2009TEAS EXTENSION RECEIVED
Wednesday, January 28, 2009STATEMENT OF USE PROCESSING COMPLETE
Monday, January 26, 2009USE AMENDMENT FILED
Monday, January 26, 2009TEAS STATEMENT OF USE RECEIVED
Friday, August 22, 2008EXTENSION 4 GRANTED
Wednesday, August 13, 2008EXTENSION 4 FILED
Friday, August 22, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 13, 2008TEAS EXTENSION RECEIVED
Tuesday, February 26, 2008EXTENSION 3 GRANTED
Thursday, February 7, 2008EXTENSION 3 FILED
Thursday, February 7, 2008TEAS EXTENSION RECEIVED
Monday, September 17, 2007EXTENSION 2 GRANTED
Thursday, July 26, 2007EXTENSION 2 FILED
Thursday, July 26, 2007TEAS EXTENSION RECEIVED
Monday, February 19, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 1, 2007EXTENSION 1 GRANTED
Thursday, February 1, 2007EXTENSION 1 FILED
Thursday, February 1, 2007TEAS EXTENSION RECEIVED
Wednesday, September 13, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 15, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 23, 2006PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2006NOTICE OF PUBLICATION
Thursday, March 30, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 24, 2006ASSIGNED TO LIE
Saturday, March 18, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 18, 2006ASSIGNED TO EXAMINER
Tuesday, September 13, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

anturol incontinence overactive urinary bladder medicaments symptoms relieve namely preparations medicines